Our cooperation is built on a shared belief. We have been partners since 2003 because of this.
Bruno Hostelet
Asia Pacific Director
BIODERMA
A long term partnership is proof of mutual trust. French dermocosmetic brand BIODERMA’s 13-year partnership with NEODERM demonstrates how only time can show the deep mutual trust and shared belief between the two companies.
“To be able to work together for so long shows that our trust is not superficial but built on a solid collaborative relationship. Three years ago, I came into contact with NEODERM for the first time, and was deeply impressed with Mr. Lim’s O2O promotional strategy. We share the belief that we can advance the beauty industry to the professional level of medicine through professional staff training, technology and innovation, while benefiting the general public with the medical, dermatological, aesthetic services and products we offer. Today, not only do we have 400 clinics, beauty centres and concept stores selling our products, we have broadened our sales network to over 500 Manning’s and Watson’s stores. We have become the number one makeup micellar water remover brand and set the record of selling one bottle every three seconds. These achievements would not have been possible without the longstanding trust between NEODERM and BIODERMA, which is now extended to our customers. The sky is the limit as to what this partnership will be able to achieve in the future."
–– Bruno Hostelet, Asia Pacific Director, BIODERMA
Bruno Hostelet
Asia Pacific Director
BIODERMA
To reaffirm our beliefs through innovation. With a firm principle, we can go even farther together.
Mark D. Steele
Chief Executive Officer
NeoStrata
The skin needs revitalising, so do partnerships. A long term partnership like that shared by NEODERM and NeoStrata is not to be taken for granted. Apart from investing time, a shared belief in innovation is the key to our collaboration, and also how we renew our relationship going forward. NeoStrata founders Dr. Van Scott and Dr. Yu took 27 years to produce AHA plant factors, demonstrating how innovation and collaboration are paramount in the field of medical aesthetics.
“NEODERM’s mission is to improve the lives of others by means of medical aesthetics. This is a unique mission that is in essence similar to ours. It is firmly anchored in innovation, as well as the ingenious application of R&D. This makes NEODERM our ideal partner in Hong Kong. For 16 years, this partnership has seen consistent business growth, thanks to their local knowledge that keeps us always a step ahead in predicting market trends. One example was the pioneering of home peel using Gel Plus in 2014, allowing NeoStrata to become one of the top five best selling brands in Asia. As close working partners, we look forward to achieving more success with NEODERM and introducing new innovations to the anti-ageing market in Hong Kong. ”
-Mark D. Steele, CEO, NeoStrata
Mark D. Steele
Chief Executive Officer
NeoStrata
Our decision to partner with NEODERM is undoubtedly one of the best decisions we have ever made!
Keith Sullivan
Chief Commercial Officer
ZELTIQ
As the world’s pioneer in CoolSculpting®, our technology that selectively treats parts of the body is the key to our success. In the same vein, we believe in selecting the right partner in order to achieve success. ZELTIQ’s great start in Hong Kong has everything to do with our selection of NEODERM as our partner. It is our big first step in entering the Hong Kong market.
“ With business partners in over 70 countries, NewBeauty Choice Award winning brand ZELTIQ specialises in CoolSculpting® from 2013 to 2015, a clinically proven procedure that freezes fat cells to create a contoured body and the world's number one treatment brand for body slimming. To maintain its market leader position, the company is highly selective when it comes to choosing a business partner. NEODERM and ZELTIQ became partners in 2013, and within four short years, its Hong Kong business has almost doubled, with a growth of 91.67%, thanks to their outstanding marketing strategies. In 2014, NEODERM won the ZELTIQ Medical Aesthetic Franchisee Award. In 2015, Hong Kong recorded a 435.71% growth in the sales of CoolSculpting treatments compared to 3 years ago. Our success proves that the decision to choose NEODERM as our partner was right.”
-Keith Sullivan, Chief Commercial Officer, ZELTIQ
Keith Sullivan
Chief Commercial Officer
ZELTIQ
It is inspiring to partner with NEODERM as its forward-looking values truly strives towards making things happen!
Valerie Lee
Regional Marketing Director, Merz Asia Pacific Pte Ltd.
Ultherapy® is a FDA-cleared technology for non-invasive skin lifting. It continues to be the leading brand in its category. Since partnering with NEODERM, Ultherapy® has successfully turned Hong Kong market to be one of the highest penetrated markets for Ultherapy in Asia.
“NEODERM’s single minded focus and aspiration to be the world-class provider of medical aesthetic solutions is a perfect fit with Merz. We started the partnership with NEODERM when we acquired the Ultheraphy® business in 2014. Undoubtedly, the transition was successful and the business that we have inherited is fundamentally strong and viable. Throughout our partnership, the team truly exemplifies the company values of “integrity, service and excellence”, of which we are impressed!”
-Valerie Lee, Regional Marketing Director, Merz Asia Pacific Pte Ltd.
Valerie Lee
Regional Marketing Director, Merz Asia Pacific Pte Ltd.